Request for Covid-19 Impact Assessment of this Report
Sales, means the sales volume of Antiandrogen
Revenue, means the sales value of Antiandrogen
This report studies sales (consumption) of Antiandrogen in Global market, especially in United States, China, Europe and Japan, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering
Pfizer
Abbott Laboratories
Genentech
GlaxoSmithKline
Immunomedics
Indevus Pharmaceuticals
Novartis AG
...
Market Segment by Regions, this report splits Global into several key Regions, with sales (consumption), revenue, market share and growth rate of Antiandrogen in these regions, from 2011 to 2021 (forecast), like
United States
China
Europe
Japan
Southeast Asia
India
Split by product Types, with sales, revenue, price and gross margin, market share and growth rate of each type, can be divided into
Type I
Type II
Split by applications, this report focuses on sales, market share and growth rate of Antiandrogen in each application, can be divided into
Application 1
Application 2
Global Antiandrogen Sales Market Report 2017
1 Antiandrogen Overview
1.1 Product Overview and Scope of Antiandrogen
1.2 Classification of Antiandrogen
1.2.1 Type I
1.2.2 Type II
1.3 Application of Antiandrogen
1.3.1 Application 1
1.3.2 Application 2
1.4 Antiandrogen Market by Regions
1.4.1 United States Status and Prospect (2012-2022)
1.4.2 China Status and Prospect (2012-2022)
1.4.3 Europe Status and Prospect (2012-2022)
1.4.4 Japan Status and Prospect (2012-2022)
1.4.5 Southeast Asia Status and Prospect (2012-2022)
1.4.6 India Status and Prospect (2012-2022)
1.5 Global Market Size (Value and Volume) of Antiandrogen (2012-2022)
1.5.1 Global Antiandrogen Sales and Growth Rate (2012-2022)
1.5.2 Global Antiandrogen Revenue and Growth Rate (2012-2022)
2 Global Antiandrogen Competition by Manufacturers, Type and Application
2.1 Global Antiandrogen Market Competition by Manufacturers
2.1.1 Global Antiandrogen Sales and Market Share of Key Manufacturers (2012-2017)
2.1.2 Global Antiandrogen Revenue and Share by Manufacturers (2012-2017)
2.2 Global Antiandrogen (Volume and Value) by Type
2.2.1 Global Antiandrogen Sales and Market Share by Type (2012-2017)
2.2.2 Global Antiandrogen Revenue and Market Share by Type (2012-2017)
2.3 Global Antiandrogen (Volume and Value) by Regions
2.3.1 Global Antiandrogen Sales and Market Share by Regions (2012-2017)
2.3.2 Global Antiandrogen Revenue and Market Share by Regions (2012-2017)
2.4 Global Antiandrogen (Volume) by Application
3 United States Antiandrogen (Volume, Value and Sales Price)
3.1 United States Antiandrogen Sales and Value (2012-2017)
3.1.1 United States Antiandrogen Sales and Growth Rate (2012-2017)
3.1.2 United States Antiandrogen Revenue and Growth Rate (2012-2017)
3.1.3 United States Antiandrogen Sales Price Trend (2012-2017)
3.2 United States Antiandrogen Sales and Market Share by Manufacturers
3.3 United States Antiandrogen Sales and Market Share by Type
3.4 United States Antiandrogen Sales and Market Share by Application
4 China Antiandrogen (Volume, Value and Sales Price)
4.1 China Antiandrogen Sales and Value (2012-2017)
4.1.1 China Antiandrogen Sales and Growth Rate (2012-2017)
4.1.2 China Antiandrogen Revenue and Growth Rate (2012-2017)
4.1.3 China Antiandrogen Sales Price Trend (2012-2017)
4.2 China Antiandrogen Sales and Market Share by Manufacturers
4.3 China Antiandrogen Sales and Market Share by Type
4.4 China Antiandrogen Sales and Market Share by Application
5 Europe Antiandrogen (Volume, Value and Sales Price)
5.1 Europe Antiandrogen Sales and Value (2012-2017)
5.1.1 Europe Antiandrogen Sales and Growth Rate (2012-2017)
5.1.2 Europe Antiandrogen Revenue and Growth Rate (2012-2017)
5.1.3 Europe Antiandrogen Sales Price Trend (2012-2017)
5.2 Europe Antiandrogen Sales and Market Share by Manufacturers
5.3 Europe Antiandrogen Sales and Market Share by Type
5.4 Europe Antiandrogen Sales and Market Share by Application
6 Japan Antiandrogen (Volume, Value and Sales Price)
6.1 Japan Antiandrogen Sales and Value (2012-2017)
6.1.1 Japan Antiandrogen Sales and Growth Rate (2012-2017)
6.1.2 Japan Antiandrogen Revenue and Growth Rate (2012-2017)
6.1.3 Japan Antiandrogen Sales Price Trend (2012-2017)
6.2 Japan Antiandrogen Sales and Market Share by Manufacturers
6.3 Japan Antiandrogen Sales and Market Share by Type
6.4 Japan Antiandrogen Sales and Market Share by Application
7 Southeast Asia Antiandrogen (Volume, Value and Sales Price)
7.1 Southeast Asia Antiandrogen Sales and Value (2012-2017)
7.1.1 Southeast Asia Antiandrogen Sales and Growth Rate (2012-2017)
7.1.2 Southeast Asia Antiandrogen Revenue and Growth Rate (2012-2017)
7.1.3 Southeast Asia Antiandrogen Sales Price Trend (2012-2017)
7.2 Southeast Asia Antiandrogen Sales and Market Share by Manufacturers
7.3 Southeast Asia Antiandrogen Sales and Market Share by Type
7.4 Southeast Asia Antiandrogen Sales and Market Share by Application
8 India Antiandrogen (Volume, Value and Sales Price)
8.1 India Antiandrogen Sales and Value (2012-2017)
8.1.1 India Antiandrogen Sales and Growth Rate (2012-2017)
8.1.2 India Antiandrogen Revenue and Growth Rate (2012-2017)
8.1.3 India Antiandrogen Sales Price Trend (2012-2017)
8.2 India Antiandrogen Sales and Market Share by Manufacturers
8.3 India Antiandrogen Sales and Market Share by Type
8.4 India Antiandrogen Sales and Market Share by Application
9 Global Antiandrogen Manufacturers Analysis
9.1 Pfizer
9.1.1 Company Basic Information, Manufacturing Base and Competitors
9.1.2 Antiandrogen Product Type, Application and Specification
9.1.2.1 Product A
9.1.2.2 Product B
9.1.3 Pfizer Antiandrogen Sales, Revenue, Price and Gross Margin (2012-2017)
9.1.4 Main Business/Business Overview
9.2 Abbott Laboratories
9.2.1 Company Basic Information, Manufacturing Base and Competitors
9.2.2 Antiandrogen Product Type, Application and Specification
9.2.2.1 Product A
9.2.2.2 Product B
9.2.3 Abbott Laboratories Antiandrogen Sales, Revenue, Price and Gross Margin (2012-2017)
9.2.4 Main Business/Business Overview
9.3 Genentech
9.3.1 Company Basic Information, Manufacturing Base and Competitors
9.3.2 Antiandrogen Product Type, Application and Specification
9.3.2.1 Product A
9.3.2.2 Product B
9.3.3 Genentech Antiandrogen Sales, Revenue, Price and Gross Margin (2012-2017)
9.3.4 Main Business/Business Overview
9.4 GlaxoSmithKline
9.4.1 Company Basic Information, Manufacturing Base and Competitors
9.4.2 Antiandrogen Product Type, Application and Specification
9.4.2.1 Product A
9.4.2.2 Product B
9.4.3 GlaxoSmithKline Antiandrogen Sales, Revenue, Price and Gross Margin (2012-2017)
9.4.4 Main Business/Business Overview
9.5 Immunomedics
9.5.1 Company Basic Information, Manufacturing Base and Competitors
9.5.2 Antiandrogen Product Type, Application and Specification
9.5.2.1 Product A
9.5.2.2 Product B
9.5.3 Immunomedics Antiandrogen Sales, Revenue, Price and Gross Margin (2012-2017)
9.5.4 Main Business/Business Overview
9.6 Indevus Pharmaceuticals
9.6.1 Company Basic Information, Manufacturing Base and Competitors
9.6.2 Antiandrogen Product Type, Application and Specification
9.6.2.1 Product A
9.6.2.2 Product B
9.6.3 Indevus Pharmaceuticals Antiandrogen Sales, Revenue, Price and Gross Margin (2012-2017)
9.6.4 Main Business/Business Overview
9.7 Novartis AG
9.7.1 Company Basic Information, Manufacturing Base and Competitors
9.7.2 Antiandrogen Product Type, Application and Specification
9.7.2.1 Product A
9.7.2.2 Product B
9.7.3 Novartis AG Antiandrogen Sales, Revenue, Price and Gross Margin (2012-2017)
9.7.4 Main Business/Business Overview
...
10 Antiandrogen Maufacturing Cost Analysis
10.1 Antiandrogen Key Raw Materials Analysis
10.1.1 Key Raw Materials
10.1.2 Price Trend of Key Raw Materials
10.1.3 Key Suppliers of Raw Materials
10.1.4 Market Concentration Rate of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
10.2.1 Raw Materials
10.2.2 Labor Cost
10.2.3 Manufacturing Process Analysis of Antiandrogen
10.3 Manufacturing Process Analysis of Antiandrogen
11 Industrial Chain, Sourcing Strategy and Downstream Buyers
11.1 Antiandrogen Industrial Chain Analysis
11.2 Upstream Raw Materials Sourcing
11.3 Raw Materials Sources of Antiandrogen Major Manufacturers in 2015
11.4 Downstream Buyers
12 Marketing Strategy Analysis, Distributors/Traders
12.1 Marketing Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
12.2.1 Pricing Strategy
12.2.2 Brand Strategy
12.2.3 Target Client
12.3 Distributors/Traders List
13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes Threat
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs/Customer Preference Change
13.3 Economic/Political Environmental Change
14 Global Antiandrogen Market Forecast (2017-2022)
14.1 Global Antiandrogen Sales, Revenue and Price Forecast (2017-2022)
14.1.1 Global Antiandrogen Sales and Growth Rate Forecast (2017-2022)
14.1.2 Global Antiandrogen Revenue and Growth Rate Forecast (2017-2022)
14.1.3 Global Antiandrogen Price and Trend Forecast (2017-2022)
14.2 Global Antiandrogen Sales, Revenue and Growth Rate Forecast by Regions (2017-2022)
14.2.1 United States Antiandrogen Sales, Revenue and Growth Rate Forecast (2017-2022)
14.2.2 China Antiandrogen Sales, Revenue and Growth Rate Forecast (2017-2022)
14.2.3 Europe Antiandrogen Sales, Revenue and Growth Rate Forecast (2017-2022)
14.2.4 Japan Antiandrogen Sales, Revenue and Growth Rate Forecast (2017-2022)
14.2.5 Southeast Asia Antiandrogen Sales, Revenue and Growth Rate Forecast (2017-2022)
14.2.6 India Antiandrogen Sales, Revenue and Growth Rate Forecast (2017-2022)
14.3 Global Antiandrogen Sales, Revenue and Price Forecast by Type (2017-2022)
14.4 Global Antiandrogen Sales Forecast by Application (2017-2022)
15 Research Findings and Conclusion
16 Appendix
Methodology
Analyst Introduction
Data Source
Figure Picture of Antiandrogen
Table Classification of Antiandrogen
Figure Global Sales Market Share of Antiandrogen by Type in 2015
Figure Type I Picture
Figure Type II Picture
Table Applications of Antiandrogen
Figure Global Sales Market Share of Antiandrogen by Application in 2015
Figure Application 1 Examples
Figure Application 2 Examples
Figure United States Antiandrogen Revenue and Growth Rate (2012-2022)
Figure China Antiandrogen Revenue and Growth Rate (2012-2022)
Figure Europe Antiandrogen Revenue and Growth Rate (2012-2022)
Figure Japan Antiandrogen Revenue and Growth Rate (2012-2022)
Figure Southeast Asia Antiandrogen Revenue and Growth Rate (2012-2022)
Figure India Antiandrogen Revenue and Growth Rate (2012-2022)
Figure Global Antiandrogen Sales and Growth Rate (2012-2022)
Figure Global Antiandrogen Revenue and Growth Rate (2012-2022)
Table Global Antiandrogen Sales of Key Manufacturers (2012-2017)
Table Global Antiandrogen Sales Share by Manufacturers (2012-2017)
Figure 2015 Antiandrogen Sales Share by Manufacturers
Figure 2016 Antiandrogen Sales Share by Manufacturers
Table Global Antiandrogen Revenue by Manufacturers (2012-2017)
Table Global Antiandrogen Revenue Share by Manufacturers (2012-2017)
Table 2015 Global Antiandrogen Revenue Share by Manufacturers
Table 2016 Global Antiandrogen Revenue Share by Manufacturers
Table Global Antiandrogen Sales and Market Share by Type (2012-2017)
Table Global Antiandrogen Sales Share by Type (2012-2017)
Figure Sales Market Share of Antiandrogen by Type (2012-2017)
Figure Global Antiandrogen Sales Growth Rate by Type (2012-2017)
Table Global Antiandrogen Revenue and Market Share by Type (2012-2017)
Table Global Antiandrogen Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Antiandrogen by Type (2012-2017)
Figure Global Antiandrogen Revenue Growth Rate by Type (2012-2017)
Table Global Antiandrogen Sales and Market Share by Regions (2012-2017)
Table Global Antiandrogen Sales Share by Regions (2012-2017)
Figure Sales Market Share of Antiandrogen by Regions (2012-2017)
Figure Global Antiandrogen Sales Growth Rate by Regions (2012-2017)
Table Global Antiandrogen Revenue and Market Share by Regions (2012-2017)
Table Global Antiandrogen Revenue Share by Regions (2012-2017)
Figure Revenue Market Share of Antiandrogen by Regions (2012-2017)
Figure Global Antiandrogen Revenue Growth Rate by Regions (2012-2017)
Table Global Antiandrogen Sales and Market Share by Application (2012-2017)
Table Global Antiandrogen Sales Share by Application (2012-2017)
Figure Sales Market Share of Antiandrogen by Application (2012-2017)
Figure Global Antiandrogen Sales Growth Rate by Application (2012-2017)
Figure United States Antiandrogen Sales and Growth Rate (2012-2017)
Figure United States Antiandrogen Revenue and Growth Rate (2012-2017)
Figure United States Antiandrogen Sales Price Trend (2012-2017)
Table United States Antiandrogen Sales by Manufacturers (2012-2017)
Table United States Antiandrogen Market Share by Manufacturers (2012-2017)
Table United States Antiandrogen Sales by Type (2012-2017)
Table United States Antiandrogen Market Share by Type (2012-2017)
Table United States Antiandrogen Sales by Application (2012-2017)
Table United States Antiandrogen Market Share by Application (2012-2017)
Figure China Antiandrogen Sales and Growth Rate (2012-2017)
Figure China Antiandrogen Revenue and Growth Rate (2012-2017)
Figure China Antiandrogen Sales Price Trend (2012-2017)
Table China Antiandrogen Sales by Manufacturers (2012-2017)
Table China Antiandrogen Market Share by Manufacturers (2012-2017)
Table China Antiandrogen Sales by Type (2012-2017)
Table China Antiandrogen Market Share by Type (2012-2017)
Table China Antiandrogen Sales by Application (2012-2017)
Table China Antiandrogen Market Share by Application (2012-2017)
Figure Europe Antiandrogen Sales and Growth Rate (2012-2017)
Figure Europe Antiandrogen Revenue and Growth Rate (2012-2017)
Figure Europe Antiandrogen Sales Price Trend (2012-2017)
Table Europe Antiandrogen Sales by Manufacturers (2012-2017)
Table Europe Antiandrogen Market Share by Manufacturers (2012-2017)
Table Europe Antiandrogen Sales by Type (2012-2017)
Table Europe Antiandrogen Market Share by Type (2012-2017)
Table Europe Antiandrogen Sales by Application (2012-2017)
Table Europe Antiandrogen Market Share by Application (2012-2017)
Figure Japan Antiandrogen Sales and Growth Rate (2012-2017)
Figure Japan Antiandrogen Revenue and Growth Rate (2012-2017)
Figure Japan Antiandrogen Sales Price Trend (2012-2017)
Table Japan Antiandrogen Sales by Manufacturers (2012-2017)
Table Japan Antiandrogen Market Share by Manufacturers (2012-2017)
Table Japan Antiandrogen Sales by Type (2012-2017)
Table Japan Antiandrogen Market Share by Type (2012-2017)
Table Japan Antiandrogen Sales by Application (2012-2017)
Table Japan Antiandrogen Market Share by Application (2012-2017)
Figure Southeast Asia Antiandrogen Sales and Growth Rate (2012-2017)
Figure Southeast Asia Antiandrogen Revenue and Growth Rate (2012-2017)
Figure Southeast Asia Antiandrogen Sales Price Trend (2012-2017)
Table Southeast Asia Antiandrogen Sales by Manufacturers (2012-2017)
Table Southeast Asia Antiandrogen Market Share by Manufacturers (2012-2017)
Table Southeast Asia Antiandrogen Sales by Type (2012-2017)
Table Southeast Asia Antiandrogen Market Share by Type (2012-2017)
Table Southeast Asia Antiandrogen Sales by Application (2012-2017)
Table Southeast Asia Antiandrogen Market Share by Application (2012-2017)
Figure India Antiandrogen Sales and Growth Rate (2012-2017)
Figure India Antiandrogen Revenue and Growth Rate (2012-2017)
Figure India Antiandrogen Sales Price Trend (2012-2017)
Table India Antiandrogen Sales by Manufacturers (2012-2017)
Table India Antiandrogen Market Share by Manufacturers (2012-2017)
Table India Antiandrogen Sales by Type (2012-2017)
Table India Antiandrogen Market Share by Type (2012-2017)
Table India Antiandrogen Sales by Application (2012-2017)
Table India Antiandrogen Market Share by Application (2012-2017)
Table Pfizer Basic Information List
Table Pfizer Antiandrogen Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Pfizer Antiandrogen Global Market Share (2012-2017)
Table Abbott Laboratories Basic Information List
Table Abbott Laboratories Antiandrogen Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Abbott Laboratories Antiandrogen Global Market Share (2012-2017)
Table Genentech Basic Information List
Table Genentech Antiandrogen Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Genentech Antiandrogen Global Market Share (2012-2017)
Table GlaxoSmithKline Basic Information List
Table GlaxoSmithKline Antiandrogen Sales, Revenue, Price and Gross Margin (2012-2017)
Figure GlaxoSmithKline Antiandrogen Global Market Share (2012-2017)
Table Immunomedics Basic Information List
Table Immunomedics Antiandrogen Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Immunomedics Antiandrogen Global Market Share (2012-2017)
Table Indevus Pharmaceuticals Basic Information List
Table Indevus Pharmaceuticals Antiandrogen Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Indevus Pharmaceuticals Antiandrogen Global Market Share (2012-2017)
Table Novartis AG Basic Information List
Table Novartis AG Antiandrogen Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Novartis AG Antiandrogen Global Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Antiandrogen
Figure Manufacturing Process Analysis of Antiandrogen
Figure Antiandrogen Industrial Chain Analysis
Table Raw Materials Sources of Antiandrogen Major Manufacturers in 2015
Table Major Buyers of Antiandrogen
Table Distributors/Traders List
Figure Global Antiandrogen Sales and Growth Rate Forecast (2017-2022)
Figure Global Antiandrogen Revenue and Growth Rate Forecast (2017-2022)
Table Global Antiandrogen Sales Forecast by Regions (2017-2022)
Table Global Antiandrogen Sales Forecast by Type (2017-2022)
Table Global Antiandrogen Sales Forecast by Application (2017-2022)
Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...
Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...
The pharmaceutical agents that are administered to treat, diagnose, and prevent life-threatening diseases (rare diseases) are known as orphan drugs. The global orphan drugs market accounted for $106 billion in 2015, and is anticipated to reach $169 billio...